Sign In
test

Oleg Nodelman

Ecor1 Capital, Llc

Assets Managed
$2.356B
Holdings
29
Last Quarter
2026 - Q1
Filed Date
1mo 5d ago
Growth Rate
6.92%(2Q avg: 6.34%)
Sustained Growth
4 quarters

Portfolio positions

This chart displays the top 10 holdings in Ecor1 Capital, Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 29 positions.

Assets under management

The assets under management (AUM) of Ecor1 Capital, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 4 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 2.356B in assets, with a quarterly growth rate of 6.92% and a 2-quarter average growth rate of 6.34%. The portfolio is managed by Oleg Nodelman, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
ZYME
Zymeworks Inc
Recent Activity
24.42%
$575.179M
22.97M shares@ $25.05 avg price
ANAB
Anaptysbio Inc
Recent Activity
18.55%
$437.03M
7.88M shares@ $55.46 avg price
JAZZ
Jazz Pharmaceuticals Plc
Recent Activity
13.7%
$322.608M
1.706M shares@ $189.05 avg price
CNTA
Centessa Pharmaceuticals-adr
Recent Activity
Increased 105.81%
10.81%
$254.637M
6.411M shares@ $39.72 avg price
CRNX
Crinetics Pharmaceuticals In
Recent Activity
6.61%
$155.745M
4.288M shares@ $36.32 avg price
AKTS
Aktis Oncology Inc
Recent Activity
New Position
3.67%
$86.31M
4.824M shares@ $17.89 avg price
ORIC
Oric Pharmaceuticals Inc
Recent Activity
3.62%
$85.245M
6.728M shares@ $12.68 avg price
CGON
Cg Oncology Inc
Recent Activity
Increased 3.5%
3.17%
$74.583M
1.102M shares@ $67.68 avg price
CRSP
Crispr Therapeutics Ag
Recent Activity
2.81%
$66.088M
1.389M shares@ $47.57 avg price
ETON
Eton Pharmaceuticals Inc
Recent Activity
Increased 6.97%
2.28%
$53.603M
2.172M shares@ $24.69 avg price

1-10 of 29